BioSpace News Archive

Insufficient policy response impedes lung-cancer control in Latin America, new EIU report finds

The Economist Intelligence Unit (EIU) has carried out two complementary studies on lung cancer in Latin America: an analysis of the economic costs and an assessment of the policy response (the Latin America Lung Cancer Traffic Lights).

September 19, 2018
·
5 min read
Feldan Therapeutics Raises $12.5 Million in Series A Financing Round

Feldan Therapeutics has announced the closing of a $12.5 million Series A financing round led by GC

September 19, 2018
·
2 min read
Business

Dominick Arena Joins Implandata Ophthalmic Products GmbH Board of Directors as Chairman

Implandata Ophthalmic Products GmbH is pleased to announce that Dominick Arena is appointed as its Chairman of the Board effective immediately.

September 19, 2018
·
1 min read
Survey reveals worldwide belief that dementia cure is possible in our lifetime

A new survey from Novartis, Amgen and Banner Alzheimer’s Institute, along with Alzheimer’s Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.

September 19, 2018
·
2 min read
Business

Ingenza’s Alison Arnold wins Scottish Women’s Award for scientific achievement

Ingenza is delighted to announce that Alison Arnold – the company’s Head of Fermentation and Microbiology – has won the Scottish Women’s Award 2018 for Services to Science and Technology.

September 19, 2018
·
1 min read
Evonetix makes key appointments to support development of novel gene synthesis technology

EVONETIX LTD announced today that it has expanded its team three-fold, following a successful series A round of £9 million ($12.3M) to support the development of the Company’s technology.

September 19, 2018
·
3 min read
Deals

Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million

Galapagos NV announced today the closing of its underwritten public offering of 2,961,373 American Depositary Shares (“ADSs”) at a price of $116.50 per ADS

September 19, 2018
·
6 min read
Biotech Bay

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

September 19, 2018
·
1 min read
Business

Precision medicine: Cap Digital and Medicen Paris Region team up with Oncodesign, Servier and Intersystems on Hu-PreciMED project

Supported by two clusters with a focus on digital and medical activities and backed by industry groups and over 45 innovative companies, the Hu-PreciMED project will gear the French precision medicine industry towards discovering new diagnostic approaches and novel therapeutic treatments more rapidly

September 19, 2018
·
8 min read
Drug Development

First Patient Dosed in Initial Immunotherapy Combination Trial Utilizing CBT’s Proprietary Assets

CBT Pharmaceuticalstoday announced the initiation of the APOLLO Oncology Clinical Trials Program.

September 19, 2018
·
4 min read